A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Page Count: 44
Table of Contents
Market Analysis: Focus on Coagulation Testing
Overview of Diagnostics in Coagulation
Market Outlook
Major Product Activity
Laboratory vs. Point-of-Care Markets
Regional Market
Top Company Briefs
Roche
Sysmex
Werfen
Executive News Briefing
Bio-Techne Appoints New President of Protein Sciences Segment
Mainz BioMed Appoints New VP of Regulatory Affairs
Lifespin GmbH Secures Financing
Numares Appoints New Member to Supervisory Board
Predicine Appoints New CFO
Financial Highlights: Agilent, Myriad Genetics and OraSure Technologies
Agilent Reports ‘Record-Setting Performance’ in Fiscal 2021
Myriad Genetics Reports 15% Growth in Third Quarter 2021
OraSure Technologies Focuses on InteliSwab Growth for FY22
Diagnostic Market Mergers, Acquisitions and Partnership Deals
What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?
One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 13th edition, this…